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Abstract
Background: Tieghemella heckelii (Sapotaceae) is a medicinal plant used in Africa, particularly in Côte d’Ivoire for
treating various diseases including infections. Identification of prospective antibacterial compounds from stem
bark of this plant as a result of its medicinal virtue, led to screening activity against methicillin resistant bacteria.
Methods: Six extracts (hexane, chloroform, ethyl acetate, ethanol, methanol and sterile distilled water) were
prepared and tested on methicillin resistant Staphylococcus aureus (MRSA) using broth microdilution method for
activity assessment. From this experiment, the minimum inhibitory concentrations (MICs) and minimum bactericidal
concentrations (MBCs) of the plant extracts were determined in sterile 96-well microplates in order to search
for both bacteriostatic and bactericidal effects. Afterwards, data analysis was performed using GraphPad Prism5
software (One-way ANOVA and Turkey Multiple Comparison test). The results were then presented as Mean ± SD
for experiment repeated three times.
Results: Four extracts (ethyl acetate, methanol, ethanol and sterile distilled water) showed credible potency, with
strong, significant, and moderate growth inhibition of the MRSA tested. The MIC values which varied from
45 μg/mL to 97 μg/mL according to microbial phenotype, resolutely established the activity of the plant extracts.
Additionally, the MBC values which varied, depending on the type of bacteria strain, revealed the bacteriostatic
and bactericidal effects of the active extracts against Methicillin-resistant Staphylococcus aureus.
Conclusion: The present study is a confirmation of the therapeutic potential of Tieghemella heckelii and its
promising contribution to the discovery of a novel antibacterial drug pertaining to these resistant strains.
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Background
Among the gram positive bacteria, Staphylococcus aureus
plays a crucial role in community and nosocomial infec-
tions. To fight against these bacteria, the beta-lactams
therapeutic class is mostly used in human medicine [1].
The molecular structure of these compounds could be
described by a beta-lactam ring attached to variable side
chains, and cycles. In fact, the pharmacokinetics, along
with the antibacterial activity of each antibiotic of this
group depend upon the structure of the attached side
chains and cycle. Unfortunately, development of several
bacteria-resistance mechanisms has caused inactivation of
available current antibiotics. Consequently, community
settings are endangered, for the pharmaceutical industry
holds as at now, few new antibiotics to offer.
The emergence or re-emergence of bacteria-resistance
has therefore become a global health concern, and public
health menace in Sub-Saharan Africa, especially in Côte
d’Ivoire, where methicillin resistance prevalence rate was
around 34.5% in 2014 [2]. On the contrary, a great num-
ber of resistant bacteria strains were identified as seriously
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challenging current antimicrobial drugs [3]. In order to
address this issue, natural products are solicited to play
an incredible role, as an alternative to eradicate the
multi-drug resistance [4]. For, in Africa more than 80%
of the populations use plants as medication towards in-
fections, and 25% of the prescriptions against infectious
diseases worldwide are plant-based. In this context,
early studies have investigated some plants used in folk
medicine [5]. Nevertheless, records in the literature do
not show data on antibacterial activity of Tieghemella
heckelii (Sapotaceae) [6].
The present study, therefore aims at screening the in
vitro assessment of this activity towards MRSA, as well
as promoting the Ivorian national flora.
Methods
Plant material
The plant material used was the stem bark of Tieghemella
heckelii Pierre ex. A Chev. (Sapotaceae). The plant species
was authenticated at the herbarium of “Centre Suisse de
Recherches Scientifiques en Côte d’Ivoire, Adiopodoumé
(Abidjan-Côte d’Ivoire)”, and registered under Voucher
number 3021. The stem bark was collected within the
period of September to October 2014 in the Haut Sassan-
dra, a mid-west region in Côte d’Ivoire.
Bacteria strains
Bacteria tested and their antibiogram, were provided
respectively by the strains collection bank (Bio-bank)
and the National Center for Antibiotics Reference at
Institut Pasteur Côte d’Ivoire. These Extended-Spectrum
Beta-Lactamases (ESBLs) harboring isolates were made
up of six methicillin-resistant Staphylococcus aureus
(MRSA). Additionally, American Type Collection Culture
(ATCC) strains were used as reference material.
Methods
Preparation of extracts
The stem bark was shade dried over 15 days, and
powdered in a mortar. Then, the extracts were prepared
by macerating successively 200 g of plant powder in 1 L
of the different solvents of increasing polarity. Extraction
was carried out for 48 h for each solvent used. After
filtration successively on hydrophilic cotton and filter
paper, the extracts were dried in an oven at 40 °C to yield
a dense residue. Each extract sample was then transferred
to a glass vial until use.
Antimicrobial assays
The different plant extracts were serially diluted from
0.048 mg/mL to 12.5 mg/mL separately in both sterile 96-
well microplates, and test tubes using broth microdilution
method [7]. Suspension (50 μL) was added to each well,
and potency (MICs) was evaluated [8]; that is the lowest
concentration of plant extract that completely inhibited
the growth of the bacterium in the well or test tube [9].
Then, the MBC values were determined by sub-culturing
the samples with no visible growth in the MIC assays. For
this purpose, the inoculum was diluted from 10−1 to 10−4
in test tubes, and streak-seeded with a calibrated loop
(2 μL) on Muller-Hinton agar. The set-up included bacter-
ial growth controls containing the test inoculum (50 μL)
and the negative controls without bacterial inoculum. Ex-
tracts controls were likewise included into the set-up. The
first batch of Petri dishes containing the agar were labelled
A, and incubated at 37 °C for 24 h. Then, after reading the
MIC values, the tube content which did not show bacteria
growth, was streak-seeded on Muller-Hinton agar. This
second batch was labelled B, and the MBCs were deter-
mined by comparing bacteria growth in A and B. The ex-
tract is said to be bacteriostatic if the ratio MBC: MIC is
equal to 4, whereas it is said to be bactericidal when it is
equal to 2.
Results
The Ethanol extract, which showed strong growth
inhibition for bacteria 408C/14, 1541C/14, 485C/14 and
446C/14, exhibited a moderate trend for bacteria 1000C/
14, and weak activity towards 499C/14. The potency of
the extract was demonstrated at a minimum inhibition
concentration value of 0.390 mg/mL, by displaying a
bacteriostatic effect for 446C/14, 408C/14, and a bacteri-
cidal activity against 1541C/14 and 485C/14. Activity
was also observed for bacteria 499C/14 and 1000C/14
respectively at MIC 1.562 and 0.781 mg/mL (Table 1).
Additionally, the Turkey Multiple Comparison showed
significant variation (P < 0.05) of the crude extract efficacy
within the range of 0.048 mg/mL to 12.5 mg/mL. Another
feature that confirmed this trend is the one-way analysis
of variance which showed a pronounced means differ-
ence of the efficacy with an R squared value of 0.6326.
Evaluation of the ethyl acetate extract showed growth
inhibition of all MRSA tested with a MIC figure of
Table 1 Antibacterial activity of crude ethanol extract of
Tieghemella heckelii on Methicillin-resistant and reference strains
of Staphylococcus aureus
Strains MIC MBC MBC/MIC Effect
408C/14 0,390 ± 0.001 1562 ± 0.001 4 Bacteriostatic
1000C/14 0,781 ± 0.001 1562 ± 0.001 2 Bactericidal
1541C/14 0,390 ± 0.001 0,781 ± 0.001 2 Bactericidal
485C/14 0,390 ± 0.001 0,781 ± 0.001 2 Bactericidal
499C/14 1562 ± 0.001 3125 ± 0.001 2 Bactericidal
446C/14 0,390 ± 0.001 1562 ± 0.001 4 Bacteriostatic
ATCCC 25923 0,781 ± 0.001 1562 ± 0.001 2 Bactericidal
MIC minimum inhibitory concentration, MBC minimum bactericidal concentration,
values are expressed as mean ± SD of 3 experiments (ANOVA and Turkey test)
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0.097 mg/mL for strains 408/C, 499C/14, 1000C/14 and
1541C/14. The plant extract has also demonstrated anti-
bacterial activity towards strains 446C/14, and 485C/14
with MIC respective values of 0.195 mg/mL and
0.781 mg/mL (Table 2). Using the Turkey Multiple
Comparison, the MIC means difference was significant
for both strains 446C/14 and 485C/14. This was con-
firmed by the one-way analysis of variance with an R
squared value of 0.6519.
Methanol extract mixed with different MRSA inocu-
lum strongly prevented the bacteria growth with MIC
highest value of 0.048 mg/mL for bacterium 1000C/14
and 0.097 mg/ml for strains 408C/14, 485C/14, and
499C/14. For 1541C/14, the extract displayed moderate
anti-MRSA potency at MIC value of 0.781 mg/mL with
a bactericidal effect, and weak activity at 1.562 mg/mL
for 446C/14 with a bacteriostatic effect (Table 3). The
statistical analysis also showed significant variation of
MIC means difference within the extract concentra-
tions range of 0.048 to 12.5 mg/mL (Turkey Multiple
Comparison test), which was confirmed by the one-way
analysis of variance (P = 0.0003; R2 = 0.5987).
Residual Aqueous extract tested on MRSA in the
screening experiment, revealed growth inhibition for
strain 408C/14 with MIC value of 6.25 mg/mL, activity
against 1000C/14 with MIC value of 3.125 mg/mL, and
growth inhibition for bacteria strains 446C/14, 485C/14,
499C/14 and 1541C/14 with MIC value of 1.562 mg/mL
(Table 4). Additionally, the extract displayed a bacteri-
cidal effect against all MRSA tested. Ultimately, the
Turkey Multiple Comparison test showed significant
variation of the extract efficacy within the concentra-
tions range. This was confirmed by the one-way analysis
of variance (P = 0.1323; R2 = 0.2013).
Discussion
The surveillance of multidrug resistance bacteria is a
crucial challenge to the global health scientists. Therefore,
the need to promote new natural compounds discovery is
to be met for the preservation of humanity. From this per-
spective, traditional medicine appears to be the way out
and as a result, it is practiced worldwide by use of
herbal plants for therapeutic purposes [10]. To illus-
trate, in the West African region, especially in Côte
d’Ivoire, people use plants as medications in rural set-
tings [11, 12]. Thus, Tieghemella heckelii is locally used
for its anti-infectious properties [11]. However, the efficacy
of the plant against multiresistant bacteria has not been
investigated. Additionally, relatively less expensive antibac-
terial need to be developed in order to address patients
subjected to infectious diseases, regardless of their living
standards with the vision to completely eradicate the anti-
bacterial drugs resistance. Early studies reported trad-
itional medicinal plants to exhibit successful activity
against methicillin-resistant Staphylococcus aureus, a
gram-positive bacterium with an outer cell wall permeable
to lipophilic solutes [13]. The results of the present study
showed that the stem bark of Tieghemella heckelii had
a great potential value against MRSA. Also, the MIC
that ranged from 0.045 mg/mL to 12.5 μg/mL with-
stood this propriety of the plant part. However, the
cutoff point was fixed at a MIC value of 0.0 97 mg/mL.
As a result, all other extract exhibiting figures above
Table 2 Antibacterial activity of ethyl acetate extract of
Tieghemella heckelii on Methicillin- resistant and reference
strains of Staphylococcus aureus
Strain MIC MBC MBC/MIC Effect
408C/14 0,097 ± 0.003 0,097 ± 0.003 1 Bactericidal
1000C/14 0,097 ± 0.003 0,390 ± 0.001 4 Bacteriostatic
1541C/14 0,097 ± 0.003 0,195 ± 0.005 2 Bactericidal
485C/14 0,781 ± 0.001 1.562 ± 0.001 2 Bactericidal
499C/14 0,390 ± 0.001 0,390 ± 0.001 1 Bactericidal
446C/14 0,195 ± 0.005 0,390 ± 0.001 2 Bactericidal
ATCC 25923 0,097 ± 0.003 0,195 ± 0.005 2 Bactericidal
MIC minimum inhibitory concentration, MBC minimum bactericidal concentration,
values are expressed as mean ± SD of 3 experiments (ANOVA and Turkey test)
Table 3 Antibacterial activity of methanol extract of Tieghemella
heckelii on Methicillin- resistant and reference strains of
Staphylococcus aureus
Strain MIC MBC MBC/MIC Effect
408C/14 0,097 ± 0.003 0,195 ± 0.005 2 Bactericidal
1000C/14 0,045 ± 0.001 0,195 ± 0.005 4 Bacteriostatic
1541C/14 0,781 ± 0.001 1562 ± 0.001 2 Bactericidal
485C/14 0,097 ± 0.003 0,195 ± 0.005 2 Bactericidal
499C/14 0,097 ± 0.003 0,097 ± 0.003 1 Bactericidal
446C/14 1562 ± 0.001 6,25 ± 0.001 4 Bacteriostatic
ATCC 25923 0,045 ± 0.001 0,097 ± 0.003 2 Bactericidal
MIC minimum inhibitory concentration, MBC: minimum bactericidal concentration,
values are expressed as mean ± SD of 3experiments (ANOVA and Turkey test)
Table 4 Antibacterial activity of aqueous extract of Tieghemella
heckelii on Methicillin- resistant and reference strains of
Staphylococcus aureus
Strains MIC MBC MBC/MIC Effect
408C/14 6,25 ± 0.001 12,5 ± 0.001 2 Bactericidal
1000C/14 3125 ± 0.005 6,25 ± 0.001 2 Bactericidal
1541C/14 1562 ± 0.001 3125 ± 0.005 2 Bactericidal
485C/14 1562 ± 0.001 3125 ± 0.005 2 Bactericidal
499C/14 1562 ± 0.001 3125 ± 0.005 2 Bactericidal
446C/14 1562 ± 0.001 3125 ± 0.005 2 Bactericidal
ATCC 25923 3125 ± 0.005 6,25 ± 0.001 2 Bactericidal
MIC minimum inhibitory concentration, MBC minimum bactericidal concentration,
values are expressed as mean ± SD of 3 experiments (ANOVA and Turkey test)
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the MIC aforementioned against the bacteria strains
was not considered. To illustrate, from the prospective
four active extracts, both the ethyl acetate and metha-
nolic extracts displayed highly strong antibacterial ac-
tivity because they exhibited MIC lowest values of
97 μg/mL and 45 μg/mL. But, methanol extract appears
to contain the most promising antibacterial agent (MIC
45 μg/mL). Additionally, plant extracts showed inhib-
ition concentrations lower than that reported else-
where. In comparison with earlier antibacterial activity
investigation, the extracts of the stem bark of Tieghe-
mella heckelii showed stronger efficacy against MRSA
than the grap-seed extract which exhibited MIC values
of 1000 μg/mL to 5000 μg/mL [14]. When compared
with studies carried out with Piper betle to assess the
antibacterial activity, the present evaluation of plant ex-
tracts’ efficacy against MRSA showed lower MIC values
compared to 78 to 156 μg/mL exhibited by the leaf ex-
tracts of Piper betle against gram positive Staphylococ-
cus aureus [13].
Conclusion
The screening experiment conducted with the MIC and
MBC determination, showed that the stem bark of
Tieghemella heckelii contains ingredients that prevent
the growth of the tested micro-organisms (6 Methicillin-
resistant Staphylococcus aureus). Therefore, they displayed
high antimicrobial properties towards the gram-positive
bacteria tested. Additionally, the lower MIC values of
0.048 and 0.097 mg/mL (Methanol and Ethyl Acetate
extracts) were respectively recorded on 16.7% and 83.3%
of the investigated MRSA species whereas the lower MBC
values of 0.097 and 0.195 mg/mL (Ethyl acetate and
Methanol extracts) exerted a credible activity on 33.3%
and 50.0% of the MRSA. These encouraging results from
the Methanol and Ethyl Acetate extracts, brought about
the perspective of further molecular purification. More-
over, the lower MBC values of the plant extract raised the
toxicity concern and further study was carried out on hu-
man cell lines to address this issue.
Consequently, the present study, which revealed the
antibacterial properties of the plant extracts, is a justi-
fication of the use of Tieghemella heckelii’s stem bark
to treat some of the tropical infectious diseases in
Africa and particularly in Côte d’Ivoire. This fact is
withstood by the bactericidal effect of the Residual
Aqueous Extract mostly used in traditional medicine.
Nevertheless, there is still room for an in depth inves-
tigation, in order to make the plant best useful to rural
settings and to select it as an alternative to bacteria
resistance.
Abbreviation
ATCC: American Type Collection Culture; DMSO: Dimethyl Sulfoxide;
ESBL: Extended-Spectrum Beta-Lactamase; GSE: Grasp-seed extract;
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SD: Standard deviation
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